Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2025
Certara (NASDAQ:CERT) will release fourth quarter and full year 2025 financial results before market open on February 26, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Certara (NASDAQ:CERT) will release fourth quarter and full year 2025 financial results before market open on February 26, 2026. Management will host a conference call to discuss results at 8:30 AM ET. Investors must register online and are advised to register at least one day early. A live and archived webcast will be available in the Investors section of Certara's website.
Details
News Market Reaction – CERT
On Jan 29, the day this news came out, CERT closed 1.49% below the previous close.
Data tracked by StockTitan Argus for the Jan 29 session.
Key Figures
- Earnings release date
- February 26, 2026
- Q4 and full-year 2025 financial results release before market open
- Earnings period
- Fourth quarter and full year 2025
- Scope of financial results to be reported
- Conference call time
- 8:30 AM ET
- Scheduled start time of management earnings call
Historical Context
-
New CEO Jon Resnick named with reaffirmed full-year 2025 outlook.
-
Q3 revenue growth, margin strength, and raised full-year 2025 guidance.
-
Launch of Phoenix Cloud TFL Studio to automate regulatory workflows.
-
Announcement of participation in multiple November investor conferences.
-
Introduction of Certara IQ, an AI-driven QSP biosimulation platform.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that it will release financial results for the fourth quarter and full year of 2025 before market open on Thursday, February 26th, 2026. Company management will host a conference call to discuss financial results at 8:30AM ET.
Investors interested in listening to the conference call are required to register online. It is recommended to register at least one day in advance.
A live and archived webcast of the event will be available on the “Investors” section of the Certara website at https://ir.certara.com/.
About Certara
Certara accelerates medicines using biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,600 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Visit us at www.certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.